chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Get a shingles vaccine / Less than two weeks later, she had the worst case of them; This case was reported by a consumer via interactive digital media and described the occurrence of shingles in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, less than 2 weeks after receiving Shingles vaccine, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingles vaccine.  Additional details were provided as follows: The case was reported by patient's best friend. The age at vaccination was not reported. The patient was convinced to get a shingles vaccine by her physician and was vaccinated. Less than two weeks post vaccination, the patient had the worst case of Shingles.
Ringing in my ears.; This is a spontaneous report from a contactable consumer. A 43-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EP7534), via an unspecified route of administration, at the age of 43 years, administered on the left arm on 24Mar2021 18:30 at a SINGLE DOSE for covid-19 immunisation. The patient's medical history was not reported. Concomitant medications included risankizumab rzaa (SKYRIZI [RISANKIZUMAB RZAA]) taken for an unspecified indication, start and stop date were not reported. The patient received first dose of COVID vaccine BNT162B2 (lot number: EN6202) on 03Mar2021 in the right arm for COVID-19 immunization. The patient experienced ringing in ears (disability) on 26Mar2021 15:45. No treatment was received for the event. The outcome of the event was not recovered.
little bit of chest tightness; like she was suppressing a cough; did not feel 100%,; drug exposure during pregnancy; Initial information received on 04-Nov-2019 regarding an unsolicited valid non-serious case received from a consumer/non-hcp.  This case involves an unknown age female patient who experienced little bit of chest tightness [PT: Chest discomfort], like she was suppressing a cough [PT Cough], did not feel 100% [PT: Malaise], and reported drug exposure during pregnancy [PT: Exposure during pregnancy], while she received vaccine influenza quadrival a-b vaccine [Fluzone Quadrivalent].   Data regarding this pregnancy were received prospectively, i.e. before pregnancy outcome was known.   The reported drug exposure during pregnancy occurred at 21 Weeks of pregnancy.   The date of last menstrual period was not reported.  The estimated due date is 16-Mar-2021.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On 30-Oct-2019, the patient received a 0.5 ml once dose of suspect influenza quadrival a-b vaccine lot UT6686JA via intramuscular route in the right arm for Prophylactic vaccination.  The patient developed a non-serious little bit of chest tightness (chest discomfort); like she was suppressing a cough (cough); did not feel 100%, (malaise) latency 1 day for all these events and reported drug exposure during pregnancy (exposure during pregnancy) latency unknown following the administration of influenza quadrival a-b vaccine.  Final diagnosis was drug exposure during pregnancy, did not feel 100%,, like she was suppressing a cough and little bit of chest tightness.  It was not reported if the patient received a corrective treatment.  Event outcome was not applicable for exposure during pregnancy and recovered for other events.  No other information was reported.
neuropathy in hands and arthritis in joint. Lost a large amount of hand strength. Aches were there never were before. My blood pressure also increased. I am now on BP meds to lower my blood pressure. No treatment for the other symptoms, which are still with me.
January 19th I had extreme pain in my stomach and chest, I went to the hospital and they diagnosed me same day with pancreatitis, I was put on medication for it omeprazole
3 am - Temp 102 (R) - mom called night nurse for advice - give TYLENOL - cranky after shots - not consolable. Had office visit and 2 ER visits.
HEADACHE, CHILLS, MUSCLE PAIN, QUARTER SIZED RED AREA HOT TO THE TOUCH, NUMBNESS OF ALL 10 FINGERS, UPPER NECK AND BACK TENSION.
A week after dose 1 developed weakness in her legs, now having worsening weakness and activity intolerance
This spontaneous case was reported by another health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (They have given 13 patients an expired Moderna vaccine) and NO ADVERSE EVENT (No Adverse Event) in an elderly patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 066H21A) for COVID-19 prophylaxis.     No Medical History information was reported.    In April 2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. In April 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (They have given 13 patients an expired Moderna vaccine). On an unknown date, the patient experienced NO ADVERSE EVENT (No Adverse Event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (They have given 13 patients an expired Moderna vaccine) and NO ADVERSE EVENT (No Adverse Event) outcome was unknown. Not Provided         This case is for 12th patient from 13 patient's case.  Concomitant product use was not provided by the reporter. It was unknown if patient receive any other vaccines in the 4 weeks prior to COVID-19 vaccine. Vials went from freezer to room temperature on days of administration. Dates of administration of vaccine were 14-Apr-2022, 21-Apr-2022, and 28-Apr-2022. Vial did not undergo any temperature excursions. 13 doses total given from 3 vials. Multi dose vial size was 5.5mL. Age group of patients were mostly over 65 and they did report all of them in the  website. Treatment information was not provided.
Information has been received from a 60 year old female licensed visiting nurse with a history of a cold in January 2008 and chickenpox (otherwise reported to be a normal healthy person with no recent stress or immunosuppression) who on unspecified dates administered Zostavax (Oka/Merck) to many patients. The patient never received Zostavax (Oka/Merck). It was noted that the patient has administered the vaccine to at least 10 patients in the last month. Subsequently the patient developed shingles. Due to her symptoms she has been home from work. The shingles has affected the left side of the patient's face and eye. The patient was seen by a physician. The patient was placed on ZOVIRAX, prednisone and VICODIN. At the time of the report the patient had not recovered. There was no product quality complaint involved. No further information was provided. Additional information has been requested. The patient considered her events to be disabling.
Flu like symptoms; Dizzy; Headache; Chills; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms), DIZZINESS (Dizzy), HEADACHE (Headache) and CHILLS (Chills) in a 96-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included DABIGATRAN ETEXILATE MESILATE (PRADAXA) and CALCIUM for an unknown indication.    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Jan-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms), DIZZINESS (Dizzy), HEADACHE (Headache) and CHILLS (Chills). At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms), DIZZINESS (Dizzy), HEADACHE (Headache) and CHILLS (Chills) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment for the symptoms included Tylenol.   Reporter did not allow further contact; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
ITP. Pt with baseline thrombocytopenia in the previous year due to liver disease, but baseline >150-160K. Pt administered Pfizer vaccine on 4/26/2021. At the time of the administration, platelet count was 183,000. The chart erroneously lists heparin as an allergy, even though HIT testing was negative. Platelet count precipitously dropped to 6,000 by 5/4/2021, although the drop began on 5/3/2021, and possibly 5/2/2021.  Pt experienced uncontrolled epistaxis, and was transfused a total of 10 units of platelets between 5/5-5/19/2021. He was treated unsuccessfully with Dexamethasone 40mg PO QD x 4, with only transient rise to 28K on 5/7/2021, and later drop back to 3K that same day. He was subsequently given IVIG 1gm/kg on 5/7/2021. After failure to improve to any significant degree, he was started on weekly Rituxan on 5/18/2021, and also given an additional two doses of IVIG 1gm/kg (on 5/21-5/22/2021). Platelet count began to rise on 5/22/2021, and had normalized by 5/31/2021.
This case was reported by a pharmacist via call center representative and described the occurrence of injection site erythema in a adult male patient who received SHINGRIX. On an unknown date, the patient received the 2nd dose of SHINGRIX (intramuscular) .5 ml. On an unknown date, less than a week after receiving SHINGRIX, the patient experienced injection site erythema and injection site swelling. On an unknown date, the outcome of the injection site erythema and injection site swelling were unknown. The reporter considered the injection site erythema and injection site swelling to be almost certainly related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient received SHINGRIX in left arm deltoid (closer to the triceps muscle). The healthcare professional did not have the lot number and expiration date of the SHINGRIX available. The time of symptom development was not reported to the healthcare professional. The patient presented to the pharmacy on the third day after vaccination. This case has been linked with US2018057887, reported by same reporter for same events. There had been no further follow-up with the patient at this point.
The patient states that when he returned home from his vaccination (approximately 30 minutes later) he started feeling dizzy, achy and tired and slept continuously for the next 2 days.  He states that he still feels dizzy (4 days post vaccination) with headache and body aches.
Collapsed, low heart rate, hospitalized at tufts Boston. Dat 2-3 POTS like symptoms. When he lo longer had cardiac symptoms he was week. So week he couldn?t walk. Complaining of pain in his knees.
treatment with Robutussin, Duonebs, Benadryl & Medrol dose pak x 2. Currently Remains on prednisone 20mg QD.
Pt had vaccine in morning. That evening approx 6pm-Mom noted that child became, pale, lethargic with lips "Blue" lasted 6-8 minutes, called 911, EMT arrivesd noted limp infant with blue lips. O2 given. Sent to hospital for eval and observation. Recovered to nl state. Observed for 24 hrs.  3/11/08 Hospital medical records of 2/25-2/26/2008.  FINAL DX: hypotonic-hyporesponsive episode as adverse immunization reaction Records reveal patient experienced unresonsiveness, lips blue, pale, limpness, clamminess lasting 8-10 min several hours s/p vaccination on day of admission.  Similar episode s/p 2 mo vax but accompanied by hysterical screaming then apnea & cyanosis for less than 1 min. Neuro, cardio & ID consults done.
inappropriate schedule of vaccine administered; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (inappropriate schedule of vaccine administered) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (inappropriate schedule of vaccine administered). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (inappropriate schedule of vaccine administered) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medication details were provided.  No concomitant medication details were provided.   Most recent FOLLOW-UP information incorporated above includes: On 06-May-2021: NNI
Kindergarten shots were given that were given 1 yr ago.No adverse effects noted at this time. parents and physician notified of event.
NUMBNESS; MINOR TINGLING; SHARP PAIN IN THE LEFT SIDE OF NECK; UNABLE TO GET LONG PERIOD OF SLEEP; WARM AT THE SITE OF INJECTION; VOMITING; NAUSEA; FATIGUE; BLINDING HEADACHE; This spontaneous report received from a patient concerned a 62 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 27-JUL-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 27-JUL-2021, the subject experienced unable to get long period of sleep. On 27-JUL-2021, the subject experienced warm at the site of injection. On 27-JUL-2021, the subject experienced vomiting. On 27-JUL-2021, the subject experienced nausea. On 27-JUL-2021, the subject experienced fatigue. On 27-JUL-2021, the subject experienced blinding headache. On an unspecified date, the subject experienced sharp pain in the left side of neck, numbness, and minor tingling. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from warm at the site of injection on 31-JUL-2021, was recovering from blinding headache, fatigue, unable to get long period of sleep, nausea, and vomiting, had not recovered from minor tingling, and numbness, and the outcome of sharp pain in the left side of neck was not reported. This report was non-serious.
Information has been received from a health professional concerning herself, a 24-26 year old female who was vaccinated intramuscularly with her third dose of GARDASIL on an unspecified date (lot# not reported). Subsequently the patient experienced injection site burning and "roaring" vaginal yeast infection. She took an over the counter medication for the vaginal yeast infection that did not help. she then called he doctor and was prescribed an unknown medication. The doctor told her they have heard of this many times. The patient received the first two doses of GARDASIL without any problem. The patient recovered on an unknown date. Additional information has been requested.
Pt recvd vax DEC91 & in MAY92 dx w/Hep B; recovered p/using natural remedies (vit c, CA Ascorbate, Licorice, Dandilion, Thistle, & various other herbs); later got 3rd inject & went ahead w/4th inject because titers were low; non-responder
typical arm swelling; headache; tiredness; This is a spontaneous report from a contactable consumer. This consumer reported similar events for 17 patients. This is the fifteenth (15th) of seventeen (17) reports.  A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number and expiry date were not provided) via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The reporter stated that they all got the vaccine shot in the village and all had the typical arm swelling, headache, and tiredness on an unspecified date. The reporter stated that also multiple friends (unspecified) had the regular side effect of soreness in the arm. The outcome of the events arm swelling, headache, and tiredness was unknown.  Information about batch/lot number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021018227 same reporter/drug/event, different patient
Boyfriend received smallpox vaccination 1/23/2006. Client was a non ocular contact transmission. Developed pustule on right wrist 2/1/2006, seen at SMC 2/3/2006.
RAISED and warm to touch 5" X 3.5" AT widest margin Biaxin 500 mg BID x10 days
Pain scale (1-10, with 1 not bad, & 10 terrible). Shot 2:30pm, 4/3/21. Sore arm within one hour (2), gradually increasing in pain intensity (5). By the evening of the first night headache (5), full body joint pain- felt like bone joints were on fire (8), nausea (4), body aches only from the waist up, and worst on the left side (6), injection site pain (6), hives? on left side of chest- raised itchy bumps, not painful (1). Hives were gone by the morning 4/4/21, all other side effects lasted throughout day 2 at the same or slightly higher pain intensity levels. Additionally around 5pm of day 2 there was an uncomfortable pressure on my chest, felt like someone had their foot on my rib cage pressing down (4). Regular breathing was fine, but I could not take a deep breath, this lasted until about 5am on 4/5/21. Today 4/5/21 there is a slight pressure remaining on my chest for deep breaths but but all other side effects, including injection site pain are gone. (I am usually fairly tolerant of pain, the joints on fire pain is the real reason I am filling this out. The other stuff was tolerable, that pain was terrible,)
Patient states his arm is sore more than 2 weeks after receiving the fluad vaccination. He states it is not warm, swollen or spreading.
within minutes of receiving the covid vaccine i became extremely dizzy and almost passed out and my heart rate shot up. it happened daily after the vaccine for a week at which point i had to call 911 and go to the hospital in an ambulance on 6/16/2021. my heart rate sky rocketed north of 170 beats per minute.  this has resulted in over 20 Emergency room visits since getting the vaccine.  i also have extreme dizziness and blurry vision still at 1 year later.
Swelling at the injection site. Sore arm. Temporary immobility/ paralysis. Redness and later bruising. Lethargy and mood swings.
The week before receiving my vaccine, I flew out of state and was working there from 10/03/2022- 10/06/2022. On 10/08/2022, I received a flu vaccine. On 10/10/2022, I began feeling sick and had a sore throat. My symptoms progressed through that week with sore throat and fatigue. On Friday, I went to a local urgent care clinic mid-day. They tested me for COVID-19, Flu, and Strep Throat. All of the tests came back negative, but the doctor thought that I may have a strep throat variant due to all of my symptoms. He prescribed Amoxicillin. Over the weekend, I still had a sore throat along with fever and chills. Today is my last day of the antibiotic. Along with the antibiotic, I was taking Tylenol, Nyquil, and Nasal Spray, and an allergy medication. I didn't leave the house from 10/14/2022 until today. I still have a bit of a horse throat, but I'm feeling better. I did begin taking a probiotic due to severe urinary incontinence. That seems to have improved now as well.
Has a sore throat; Stuffy nose; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (159558). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 26Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history was not reported. The patient took concomitant medications. The following information was reported: OROPHARYNGEAL PAIN (non-serious), outcome "unknown", described as "Has a sore throat"; NASAL CONGESTION (non-serious), outcome "unknown", described as "Stuffy nose". Therapeutic measures were taken as a result of oropharyngeal pain, nasal congestion.  Additional information: Patent took Benadryl  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Within 1 hour of shot eyes red, swollen, vision blurred. Throat started to close. Administered BENADRYL every 3 to 4 hours for two days. Continued pain and decrease range of motion in arm shot given joint pain and stiffness as well.
This spontaneous report as received from a consumer refers to a 11-year-old female patient. The patient had no pertinent medical history and no drug reactions or allergies. However, it was reported that the patient experienced injection site pain after receiving an unspecified flu vaccine in the past. On 15-SEP-2017, the patient was vaccinated with GARDASIL 9 (exact dose, route of administration, lot number and expiration date were not provided) for prophylaxis. On 17-SEP-2018, the patient received GARDASIL 9 lot # N035955, intramuscular for prophylaxis. Other suspect therapies included an unspecified flu vaccine (dose and route not provided) given on the same day as a second dose of GARDASIL 9. Concomitant therapies included diphtheria toxoid, pertussis acellular vaccine (unspecified), tetanus toxoid, meningococcal acyw polysaccharide vaccine and meningococcal polysaccharide vaccine (unspecified). It was reported that the GARDASIL 9 shot hurt when it was administered and the patient also experienced pain at the injection site afterwards. The patient's mother stated that she did not remember if her daughter experienced any pain after receiving her first dose of GARDASIL 9. She also noted that the patient was given the 2 dose regimen because of the patient's age, but the second dose was later than 12 months after the first one. Additionally, it was reported that the patient experienced injection site pain also where the flu vaccine was administered. The patient received an unspecified treatment for the event but no lab diagnostics were performed. She did not seek medical attention. The outcome of injection site pain was reported as recovering. The relatedness between the event and the suspect vaccines was not provided by the reporter.
Pt received Prevnar on 12/10/2001. She became ill on 12/14/2001. She developed meningitis. I question if vaccine actually lowered immunity to pneumococcus or was this coincidence.
This spontaneous report as received from a physician refers to a 6 month old patient. On 05-FEB-2013, the patient was vaccinated with the first 2 ml dose of live, oral ROTATEQ (Lot # not reported). No adverse effect was reported. Additional information is not expected.
Pt started turning pale and sweaty. Pt started to shake a little and was laid of the floor gently by the pharmacist.  The paramedics were called right and blood pressure was taken while pt was on the floor.  The patient came to while laying on the floor and said he did not remember going onto the floor. The paramedics came and checked out the pt but denied them going to the hospital. Pt was told to follow up with md to make sure he doesn't have any issues with seizures.
After administering the vaccine, patient developed a lump at the injection site. Patient was bleeding profusely. After a few minutes of applying pressure, patient stopped bleeding. Lump was still present when patient left facility.
Hot, red, swollen, itchy.  R deltoid.  ATARAX.